Stem Cells 2023 _ Event Postponement
This is to inform that due to some circumstances beyond the organizer control, "2nd Edition of International Conference on Cell & Stem Cell Research" (Stem Cells 2023) August 21-23, 2023 | Hybrid Event has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at stem-cell@magnusconference.com or call + 1 (702) 988 2320.
2nd Edition of International Conference on Cell & Stem Cell Research
August 21-23, 2023 | London, UK
Cellular Reprogramming and Stem Cell Biology
The process of converting mature, specialised cells into induced pluripotent stem cells is known as cell reprogramming. During mammalian germ cell development, reprogramming also refers to the erasure and re-establishment of epigenetic markers. The use of cellular reprogramming technologies to replace cells lost due to diseases or accidents holds a lot of promise for tissue repair and regeneration. Advances in cellular reprogramming, in addition to the ground breaking discovery of induced pluripotent stem cells, allow for direct lineage conversion of one somatic cell type to another utilising specific transcription factors.
- Advanced Experimental Design
- Methods and Analysis in Stem Cell Biology
- Gene Editing and Cell-Based Therapies
Alain chapel
Institute of Radiological Protection and Nuclear Safety, France
P K Prem Ravi Varma
Cancer Research Centre, India
Ahmed G Hegazi
National Research Center, Egypt
Alain chapel
Institute of Radiological Protection and Nuclear Safety, FranceSubmit your abstract Today
Title : The adult stem cells and the cancer stem cells in the context of ovarian cancer
Pushpam Kumar Sinha, Independent Researcher, India
Title : Cell based therapies in articular cartilage repair
Anjali Goyal, NHL Municipal Medical College, India
Title : Comparative study on the effect of adipose-derived stem cells versus alpha-lipoic acid inautologus fat graft survival
Sahar Mohamed Mahdy Omar, Ain Shams University, Egypt
Title : Mesenchymal stem cell therapy: A review of clinical trials for multiple sclerosis
Asma Alanazi, King Saud Bin Abdulaziz University, Saudi Arabia
Title : Stem cell therapy in radiotherapy from bench to clinical trial evaluating the efficacy of Mesenchymal stromal cell injections for the treatment of chronic pelvic complications induced by radiation therapy
Alain chapel, Institute of Radiological Protection and Nuclear Safety, France
Title : Optimized protocol for generating clinical grade umbilical cord tissue mesenchymal stem cell for cell therapy in various disease
Rekha Kumari, Institute of Liver and Billiary Sciences, India